Search clinical trials for: Keppra, Levetiracetam

Total 259 results

Loyola University

Unknown

Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?

Seizures | Traumatic Brain Injury

United States
Washington University School of Medicine

Completed

Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH (DOPAST)

Subarachnoid Hemorrhage

United States
UCB Japan Co. Ltd.

Completed

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

Epilepsy, Partial
Zagazig University

Completed

Effect of Valproate Versus Levetiracetam Monotherapy on Reproductive Functions in Epileptic Males

Epilepsy
New York State Psychiatric Institute
UCB Pharma

Completed

Levetiracetam for the Treatment of Alcohol Dependence and Anxiety

Alcoholism | Anxiety Disorders | Generalized Anxiety Disorder | Panic Disorder | Social Phobia

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders

Sickle Cell Disease

United States
UCB Japan Co. Ltd.

Completed

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Epilepsy | Generalized Tonic-Clonic Seizures

China, Japan
University of South Florida

Terminated

Keppra for Cervical Dystonia (Keppra)

Cervical Dystonia
UCB Pharma SA

Completed

Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.

Epilepsy, Tonic-clonic

Poland, Sweden, Hungary, Czechia
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital; Newton-Wellesley Hospital

Completed

Premenstrual Dysphoric Disorder and Antiepileptic Drugs

Epilepsy

United States
Drexel University College of Medicine
UCB Pharma

Completed

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

Epilepsy

United States
Massachusetts General Hospital
UCB Pharma; GlaxoSmithKline; UCB Young Investigator Research Program; National...

Completed

Cognitive Effects of Treatment of Interictal Discharges

Epilepsy

United States
UCB Pharma

Completed

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (VERVE)

Epilepsy

United States, Australia, Bulgaria, Denmark, France, Germany, Romania, Spain, Sweden
UCB Pharma SA

Completed

Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)

Epilepsy

United States, France, Germany, Spain, United Kingdom
Medical University of South Carolina
UCB Pharma

Withdrawn

Efficacy of Keppra in Acute Alcohol Related Seizure Control--A Pilot Study

Seizure, Alcohol Related

United States
Hannover Medical School

Terminated

Pharmacovigilance in Gerontopsychiatric Patients (GAP)

Depression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic Disorders

Germany
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 1g Under Fasted Conditions

Seizures

United States
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fasting Conditions

Seizures

United States
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions

Seizures

United States
Roxane Laboratories

Completed

Bioequivalency Study of Levetiracetam 1g Tablets Under Fed Conditions

Seizures

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients (Keppra-DB)

Opioid Dependency | Cocaine Dependence

United States
Masonic Cancer Center, University of Minnesota

Terminated

T-Cell Depleted Double UCB for Refractory AML

Acute Myelogenous Leukemia | Refractory Acute Myelogenous Leukemia

United States
Thomas Jefferson University
National Institute of Neurological Disorders and Stroke (NINDS)

Terminated

Antiepileptic Drugs and Vascular Risk Markers

Subarachnoid Hemorrhage
Children's Hospital Medical Center, Cincinnati
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children (FIRST)

Benign Childhood Epilepsy With Centro-Temporal Spikes

United States
Vanderbilt University Medical Center

Withdrawn

Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study (SPLASH - Pilot)

Seizures | Subarachnoid Hemorrhage

United States
UCB Pharma
Yale University; PRA Health Sciences

Completed

A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers

Healthy Volunteers

United States
Emory University
Patient-Centered Outcomes Research Institute

Terminated

Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE) (COPE)

Epilepsy, Partial | Epilepsy, Localization Related

United States
Mid-Atlantic Epilepsy and Sleep Center, LLC

Withdrawn

Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus

Epilepsy | Status Epilepticus

United States
UCB Pharma

Terminated

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (VICTOR)

Epilepsy, Partial

Austria, Germany, Spain
Johns Hopkins University
National Institute on Aging (NIA)

Completed

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI)

United States
UCB Korea Co., Ltd.

Completed

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Epilepsy

Korea, Republic of
UCB Pharma SA

Completed

Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

Epilepsy | Partial Seizures

China
UCB Pharma

Completed

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Epilepsy | Generalized Tonic-clonic Seizures

Japan
National Institute of Neurological Disorders and...

Completed

Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia

Oromandibular Dystonia | Cranial Dystonia

United States
Brigham and Women's Hospital

Completed

Add on Lacosamide Versus High Dose Monotherapy

Epilepsy

United States
University College, London
The Leeds Teaching Hospitals NHS Trust; Cambridge University Hospitals NHS... and other collaborators

Unknown

Ketogenic Diet in Infants With Epilepsy (KIWE) (KIWE)

Epilepsy

United Kingdom
Cairo University

Unknown

Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG

Neonatal Seizures

Egypt
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

Seizure
Boston University
UCB Pharma

Completed

The Effects of Levetiracetam on Alcohol Dependent Subjects

Alcoholism

United States
Elpen Pharmaceutical Co. Inc.

Completed

LevetIracetam in Patients Being Treated for Epilepsy (LIBERTY)

Epilepsy

Greece
Yale University

Completed

Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. (Keppra)

Opioid Dependence | Cocaine Dependence

United States
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

Epilepsy | Partial Seizures
Beijing Pins Medical Co., Ltd

Unknown

Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)

Epileptic Encephalopathy

China
Banaras Hindu University
Institute of Medical Sciences of the Banaras Hindu University (BHU),India

Completed

Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus

Grand Mal Status Epilepticus
National Institute of Neurological Disorders and...

Completed

Levetiracetam Treatment of L-dopa Induced Dyskinesias

Parkinson Disease | Dyskinesias

United States
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (LVT1)

Epilepsy | Seizure | Cerebral Malaria

Malawi
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM (LVT2)

Epilepsy | Seizure | Cerebral Malaria

Malawi
Seoul National University Hospital

Unknown

Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients

Glioblastoma Multiforme
Inflamax Research Incorporated

Completed

Irritation and Sensitization Potential of Repeat Applications of Rotigotine Patch

Bioequivalence - Irritation and Sensitization Potential of Transdermal Patch

United States, Canada
Indiana University

Terminated

Seizure Prophylaxis in Aneurysm Repair

Seizures | Intracranial Aneurysms

United States

Search clinical trials for: Keppra, Levetiracetam

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations